Skip to Content

In the News: Bruce Merenstein’s Role as Special Master and Mediator in Avandia Fee Dispute

On January 23, 2013 by Schnader in Litigation

Several news organizations have reported on the work of Schnader partner Bruce P. Merenstein with regard to his role as special master and mediator in the consolidated Avandia marketing and product liability litigation against GlaxoSmithKline.

Bloomberg: “Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million

Law360: “Attorneys Agree to $143 million Fee Split in $2.3 billion Avandia MDL

Thomson Reuters: “Avandia Case: The New Normal for Plaintiffs’ Fees in Mass Torts?

WRALtechwire: “Lawyers Fight Over Split of $143 Million in Fees for GSK Avandia Settlement

Law.com: “Attorneys Settle Objections to Distribution Of $144 Million in Avandia Legal Fees